FTC sues to block Amgen acquisition of Horizon Therapeutics

📆 16/05/2023 15:02:00
📰 CNBC

⏱ Reading Time:
21 sec. here
2 min. at publisher
📊 Quality Score:
News: 12%
Publisher: 72%

Brasil Notícia Notícia

Brasil Últimas Notícias,Brasil Manchetes

The deal was a bid to strengthen Amgen's drug portfolio as it prepares to face several patent expirations for key treatments over the next decade.

Sources familiar with the matter told CNBC's David Faber earlier Tuesday that Amgen is prepared to defend the acquisition, with one source adding the company expects to "win big."

Representatives for Amgen and for Horizon Therapeutics did not immediately respond to a request for comment from CNBC.The two drugmakers said in February that the FTC sent themThousand Oaks, California-based Amgen to buy Horizon Therapeutics in early December and said it expected to complete the sale in the first half of this year.for key treatments over the next decade.CNBC Health & Science

Escrever Comentário

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Robocall company behind 'billions' of illegal calls sued by FTCXCast Labs, a company accused of helping make billions of illegal robocalls, was sued on Friday by the U.S. Federal Trade Commission, which asked the court to order the company to stop the practice.
Fonte: Reuters - 🏆 2. / 97 Consulte Mais informação »